OR WAIT null SECS
September 27, 2022
Pfizer is set to supply global fund up to 6 million treatment courses of its COVID-19 oral treatment, PAXLOVID, for low-and-middle-income countries.
Aprecia has hired Chris Lockwood as head of technical services at its Ohio facility.
September 23, 2022
Legislative leaders are looking to approve a bare-bones measure to fund FDA operations as part of a short-term government funding bill.
September 21, 2022
The Public-Private Partnership for Rare Neurodegenerative Diseases will work to enhance understanding and develop treatments for rare neurodegenerative diseases.
Lonza has expanded its HPAPI multipurpose suite for payload-linker manufacturing.
September 20, 2022
Regulatory officials are addressing challenges in ensuring that clinical data can be relied on in making regulatory decisions.
CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.
September 19, 2022
Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.
Novo Nordisk and Microsoft are collaborating to accelerate drug discovery and development using big data and artificial intelligence.
Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.